European Stocks Higher; Moderna Vaccine News Helps Sentiment By Investing.com – Investing.com

European Stocks Higher; Moderna Vaccine News Helps Sentiment By Investing.com – Investing.com

© Reuters.

By Peter Nurse 

Investing.com - European stock markets traded higher Tuesday, rebounding after the previous session’s hefty losses, but concerns about the risks associated with the Omicron Covid-19 variant remain.

At 3:55 AM ET (0855 GMT), the in Germany traded 0.7% higher, the in France rose 0.8% and the U.K.’s climbed 1%. 

Helping the tone Tuesday was the news from Moderna (NASDAQ:) that the U.S. drugmaker could develop a booster shot to protect against the Omicron variant in a relatively short period.

"It only needs minor adjustments for Omicron. I don't expect any problems," CEO Stephane Bancel said in an interview with the Swiss newspaper TagesAnzeiger published on Tuesday.

The European Union has also approved the use of Novavax 's (NASDAQ:) vaccine in people aged 18 or over, making it the fifth shot available for use within the bloc.

European equity indexes sold off sharply on Monday, with the DAX in Germany dropping almost 2%, after various countries in the region adopted restrictive measures to stop the spread of the virulent Omicron strain of the Covid-19 virus, including the Netherlands imposing a full lockdown of non-essential stores.

New Zealand delayed